UiPath, Inc. (NYSE:PATH - Get Free Report)'s stock price dropped 8.5% during trading on Tuesday . The company traded as low as $10.99 and last traded at $11.0960. Approximately 9,222,207 shares traded hands during trading, a decline of 73% from the average daily volume of 34,143,063 shares. The stock had previously closed at $12.13.
Analysts Set New Price Targets
A number of analysts recently weighed in on the stock. DA Davidson lowered their target price on shares of UiPath from $15.00 to $13.00 and set a "neutral" rating on the stock in a research note on Thursday, March 12th. Wells Fargo & Company decreased their price objective on UiPath from $14.00 to $13.00 and set an "equal weight" rating on the stock in a report on Thursday, March 12th. Royal Bank Of Canada set a $14.00 target price on UiPath in a report on Wednesday, February 11th. TD Cowen cut their target price on UiPath from $16.00 to $13.00 and set a "hold" rating for the company in a research report on Thursday, March 12th. Finally, Truist Financial decreased their price target on UiPath from $17.00 to $12.00 and set a "hold" rating on the stock in a research note on Thursday, March 12th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $14.07.
Check Out Our Latest Stock Analysis on UiPath
UiPath Price Performance
The firm has a 50 day simple moving average of $12.39 and a two-hundred day simple moving average of $14.07. The stock has a market cap of $5.87 billion, a price-to-earnings ratio of 21.11, a price-to-earnings-growth ratio of 1.97 and a beta of 1.09.
UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings data on Wednesday, March 11th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.25 by $0.05. The business had revenue of $481.11 million for the quarter, compared to the consensus estimate of $464.81 million. UiPath had a return on equity of 5.69% and a net margin of 17.53%.The firm's revenue was up 13.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.26 EPS. On average, sell-side analysts expect that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.
Insider Buying and Selling at UiPath
In other news, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction on Monday, January 26th. The stock was sold at an average price of $15.01, for a total transaction of $675,450.00. Following the completion of the sale, the chief executive officer owned 27,893,585 shares of the company's stock, valued at approximately $418,682,710.85. This trade represents a 0.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Ashim Gupta sold 67,468 shares of the business's stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $16.10, for a total transaction of $1,086,234.80. Following the completion of the sale, the chief financial officer directly owned 557,028 shares of the company's stock, valued at approximately $8,968,150.80. The trade was a 10.80% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 607,468 shares of company stock valued at $9,893,635 over the last 90 days. 23.19% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of PATH. Purpose Unlimited Inc. bought a new position in UiPath in the 4th quarter valued at about $115,000. Corient Private Wealth LLC raised its holdings in UiPath by 5.6% during the 4th quarter. Corient Private Wealth LLC now owns 27,283 shares of the company's stock worth $447,000 after purchasing an additional 1,455 shares during the last quarter. Avory & Company LLC acquired a new position in shares of UiPath in the 4th quarter worth approximately $275,000. Invesco Ltd. boosted its stake in shares of UiPath by 32.1% in the 4th quarter. Invesco Ltd. now owns 1,202,277 shares of the company's stock valued at $19,705,000 after purchasing an additional 292,134 shares during the last quarter. Finally, Mercer Global Advisors Inc. ADV lifted its stake in shares of UiPath by 31.4% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 38,330 shares of the company's stock valued at $619,000 after purchasing an additional 9,151 shares during the period. Institutional investors and hedge funds own 62.50% of the company's stock.
UiPath Company Profile
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report